Roquefort Therapeutics plc

ROQ.L · LSE
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-£1-£2-£2-£1
Dep. & Amort.£0£0£0£0
Deferred Tax£0£0£0£0
Stock-Based Comp.£0£0£0£0
Change in WC£0-£0£0-£2
Other Non-Cash£0£0£0£0
Operating Cash Flow-£1-£2-£2-£3
Investing Activities
PP&E Inv.£0-£0£0£0
Net Acquisitions£0£0-£0-£1
Inv. Purchases£0£0£0£0
Inv. Sales/Matur.£0£0£0£0
Other Inv. Act.£0£0£0£0
Investing Cash Flow£0-£0-£0-£1
Financing Activities
Debt Repay.£1£0£0£0
Stock Issued£0£0£3£5
Stock Repurch.£0£0£0£0
Dividends Paid£0£0£0£0
Other Fin. Act.£0-£0-£0£0
Financing Cash Flow£1-£0£3£5
Forex Effect-£0£0£0-£0
Net Chg. in Cash-£0-£2£1£1
Supplemental Information
Beg. Cash£1£2£1-£0
End Cash£0£1£2£1
Free Cash Flow-£1-£2-£2-£3
Roquefort Therapeutics plc (ROQ.L) Financial Statements & Key Stats | AlphaPilot